Giorgio Iannella - EssilorLuxottica CoHead Relations
| ESL Stock | EUR 228.80 2.50 1.08% |
Insider
Giorgio Iannella is CoHead Relations of EssilorLuxottica Socit anonyme
| Phone | 33 1 49 77 42 16 |
| Web | https://www.essilorluxottica.com |
EssilorLuxottica Management Efficiency
The company has return on total asset (ROA) of 0.0336 % which means that it generated a profit of $0.0336 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0615 %, meaning that it generated $0.0615 on every $100 dollars invested by stockholders. EssilorLuxottica's management efficiency ratios could be used to measure how well EssilorLuxottica manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Brett Sandercock | Resmed Inc DRC | 56 | |
| Mei Wang | Sartorius Aktiengesellschaft | N/A | |
| Robert Douglas | Resmed Inc DRC | 63 | |
| Urvashi Tyagi | Resmed Inc DRC | N/A | |
| BE MBA | Resmed Inc DRC | 50 | |
| Vered Keisar | ResMed Inc | N/A | |
| Gary Guthart | Intuitive Surgical | 57 | |
| Petra Kirchhoff | Sartorius Aktiengesellschaft | 54 | |
| BE MBA | ResMed Inc | 50 | |
| Constance Bienfait | ResMed Inc | N/A | |
| Rene Faber | Sartorius Aktiengesellschaft | 48 | |
| AM AM | ResMed Inc | 80 | |
| Rene Faber | Sartorius Stedim Biotech | 43 | |
| Olivier Guitard | Sartorius Stedim Biotech | N/A | |
| Julian Nikolchev | Intuitive Surgical | 69 | |
| Amelie Buton | Sartorius Stedim Biotech | 32 | |
| Brett Sandercock | ResMed Inc | 56 | |
| AM AM | Resmed Inc DRC | 80 | |
| Manohar Kuppusami | Sartorius Aktiengesellschaft | N/A | |
| Jamie Samath | Intuitive Surgical | 52 | |
| John Mackay | Sartorius Stedim Biotech | 61 | |
Management Performance
| Return On Equity | 0.0615 | |||
| Return On Asset | 0.0336 |
EssilorLuxottica Socit Leadership Team
Elected by the shareholders, the EssilorLuxottica's board of directors comprises two types of representatives: EssilorLuxottica inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EssilorLuxottica. The board's role is to monitor EssilorLuxottica's management team and ensure that shareholders' interests are well served. EssilorLuxottica's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EssilorLuxottica's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Paul Saillant, Deputy Director | ||
| Giorgio Iannella, CoHead Relations | ||
| Marco Catalani, Head Communications | ||
| Francesco Milleri, Chairman CEO | ||
| Ariel Bauer, CoHead Relations | ||
| Stefano Grassi, Chief Officer |
EssilorLuxottica Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EssilorLuxottica a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0615 | |||
| Return On Asset | 0.0336 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.13 % | |||
| Current Valuation | 90.35 B | |||
| Shares Outstanding | 445.34 M | |||
| Shares Owned By Insiders | 36.17 % | |||
| Shares Owned By Institutions | 29.28 % | |||
| Price To Earning | 29.20 X | |||
| Price To Book | 2.11 X |
Currently Active Assets on Macroaxis
Other Information on Investing in EssilorLuxottica Stock
EssilorLuxottica financial ratios help investors to determine whether EssilorLuxottica Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EssilorLuxottica with respect to the benefits of owning EssilorLuxottica security.